Mereo BioPharma Group plc (NASDAQ:MREO) Receives $7.71 Consensus Price Target from Brokerages
Shares of Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eight research firms that are currently covering the company, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The […]
Shares of Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eight research firms that are currently covering the company, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The […]
